{"count": 5, "results": [{"_id": "34843676", "pmid": 34843676, "title": "Simvastatin potentiates the cell-killing activity of imatinib in imatinib-resistant chronic myeloid leukemia cells mainly through PI3K/AKT pathway attenuation and Myc downregulation.", "journal": "Eur J Pharmacol", "authors": ["Ding L", "Chen Q", "Chen K", "Jiang Y", "Li G", "Chen Q", "Bai D", "Gao D", "Deng M", "Zhang H", "Xu B"], "date": "2021-12-15T00:00:00Z", "doi": "10.1016/j.ejphar.2021.174633", "meta_date_publication": "2021 Dec 15", "meta_volume": "913", "meta_issue": "", "meta_pages": "174633", "score": 50261.14, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ potentiates the cell-killing activity of @CHEMICAL_Imatinib_Mesylate @CHEMICAL_MESH:D000068877 @@@imatinib@@@ in @CHEMICAL_Imatinib_Mesylate @CHEMICAL_MESH:D000068877 @@@imatinib@@@-resistant @<m>DISEASE_Leukemia_Myelogenous_Chronic_BCR_ABL_Positive</m> @DISEASE_MESH:D015464 @@@chronic myeloid leukemia@@@ cells mainly through PI3K/@GENE_AKT1 @GENE_207 @@@AKT@@@ pathway attenuation and @GENE_MYC @GENE_4609 @@@Myc@@@ downregulation.", "citations": {"NLM": "Ding L, Chen Q, Chen K, Jiang Y, Li G, Chen Q, Bai D, Gao D, Deng M, Zhang H, Xu B. Simvastatin potentiates the cell-killing activity of imatinib in imatinib-resistant chronic myeloid leukemia cells mainly through PI3K/AKT pathway attenuation and Myc downregulation. Eur J Pharmacol. 2021 Dec 15;913():174633. PMID: 34843676", "BibTeX": "@article{34843676, title={Simvastatin potentiates the cell-killing activity of imatinib in imatinib-resistant chronic myeloid leukemia cells mainly through PI3K/AKT pathway attenuation and Myc downregulation.}, author={Ding L and Chen Q and Chen K and Jiang Y and Li G and Chen Q and Bai D and Gao D and Deng M and Zhang H and Xu B}, journal={Eur J Pharmacol}, volume={913}, pages={174633}}"}}, {"_id": "18824851", "pmid": 18824851, "title": "In vitro and in vivo study of cell growth inhibition of simvastatin on chronic myelogenous leukemia cells.", "journal": "Chemotherapy", "authors": ["Yang YC", "Huang WF", "Chuan LM", "Xiao DW", "Zeng YL", "Zhou DA", "Xu GQ", "Liu W", "Huang B", "Hu Q"], "date": "2008-01-01T00:00:00Z", "doi": "10.1159/000158663", "meta_date_publication": "2008", "meta_volume": "54", "meta_issue": "6", "meta_pages": "438-46", "score": 50070.43, "text_hl": "In vitro and in vivo study of cell growth inhibition of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Leukemia_Myelogenous_Chronic_BCR_ABL_Positive</m> @DISEASE_MESH:D015464 @@@chronic myelogenous leukemia@@@ cells.", "citations": {"NLM": "Yang YC, Huang WF, Chuan LM, Xiao DW, Zeng YL, Zhou DA, Xu GQ, Liu W, Huang B, Hu Q. In vitro and in vivo study of cell growth inhibition of simvastatin on chronic myelogenous leukemia cells. Chemotherapy. 2008;54(6):438-46. PMID: 18824851", "BibTeX": "@article{18824851, title={In vitro and in vivo study of cell growth inhibition of simvastatin on chronic myelogenous leukemia cells.}, author={Yang YC and Huang WF and Chuan LM and Xiao DW and Zeng YL and Zhou DA and Xu GQ and Liu W and Huang B and Hu Q}, journal={Chemotherapy}, volume={54}, number={6}, pages={438-46}}"}}, {"_id": "20354828", "pmid": 20354828, "title": "Combination of simvastatin and imatinib sensitizes the CD34+ cells in K562 to cell death.", "journal": "Med Oncol", "authors": ["Chen R", "Xiao W", "Li D", "Mu S"], "date": "2011-06-01T00:00:00Z", "doi": "10.1007/s12032-010-9472-9", "meta_date_publication": "2011 Jun", "meta_volume": "28", "meta_issue": "2", "meta_pages": "528-31", "score": 50064.246, "text_hl": "Our data here point out that combination of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Imatinib_Mesylate @CHEMICAL_MESH:D000068877 @@@imatinib@@@ could be a therapeutic option for the resistant @<m>DISEASE_Leukemia_Myelogenous_Chronic_BCR_ABL_Positive</m> @DISEASE_MESH:D015464 @@@CML@@@.", "citations": {"NLM": "Chen R, Xiao W, Li D, Mu S. Combination of simvastatin and imatinib sensitizes the CD34+ cells in K562 to cell death. Med Oncol. 2011 Jun;28(2):528-31. PMID: 20354828", "BibTeX": "@article{20354828, title={Combination of simvastatin and imatinib sensitizes the CD34+ cells in K562 to cell death.}, author={Chen R and Xiao W and Li D and Mu S}, journal={Med Oncol}, volume={28}, number={2}, pages={528-31}}"}}, {"_id": "23075630", "pmid": 23075630, "title": "Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells.", "journal": "Anticancer Drugs", "authors": ["Oh B", "Kim TY", "Min HJ", "Kim M", "Kang MS", "Huh JY", "Kim Y", "Lee DS"], "date": "2013-01-01T00:00:00Z", "doi": "10.1097/CAD.0b013e32835a0fbd", "meta_date_publication": "2013 Jan", "meta_volume": "24", "meta_issue": "1", "meta_pages": "20-31", "score": 50062.918, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ also killed primary CD34 cells from @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Leukemia_Myelogenous_Chronic_BCR_ABL_Positive</m> @DISEASE_MESH:D015464 @@@CML@@@ more efficiently, compared with CD34 @<m>DISEASE_Leukemia_Myelogenous_Chronic_BCR_ABL_Positive</m> @DISEASE_MESH:D015464 @@@CML@@@ cells. ", "citations": {"NLM": "Oh B, Kim TY, Min HJ, Kim M, Kang MS, Huh JY, Kim Y, Lee DS. Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells. Anticancer Drugs. 2013 Jan;24(1):20-31. PMID: 23075630", "BibTeX": "@article{23075630, title={Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells.}, author={Oh B and Kim TY and Min HJ and Kim M and Kang MS and Huh JY and Kim Y and Lee DS}, journal={Anticancer Drugs}, volume={24}, number={1}, pages={20-31}}"}}, {"_id": "26911804", "pmid": 26911804, "title": "Simvastatin in combination with bergamottin potentiates TNF-induced apoptosis through modulation of NF-kappaB signalling pathway in human chronic myelogenous leukaemia.", "journal": "Pharm Biol", "authors": ["Kim SM", "Lee EJ", "Lee JH", "Yang WM", "Nam D", "Lee JH", "Lee SG", "Um JY", "Shim BS", "Ahn KS"], "date": "2016-10-01T00:00:00Z", "doi": "10.3109/13880209.2016.1141221", "meta_date_publication": "2016 Oct", "meta_volume": "54", "meta_issue": "10", "meta_pages": "2050-60", "score": 50055.797, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in combination with @CHEMICAL_bergamottin @CHEMICAL_MESH:C068337 @@@bergamottin@@@ potentiates @GENE_TNF @GENE_7124 @@@TNF@@@-induced apoptosis through modulation of @GENE_NFKB1 @GENE_4790 @@@NF-kappaB@@@ signalling pathway in @SPECIES_9606 @@@human@@@ @<m>DISEASE_Leukemia_Myelogenous_Chronic_BCR_ABL_Positive</m> @DISEASE_MESH:D015464 @@@chronic myelogenous leukaemia@@@.", "citations": {"NLM": "Kim SM, Lee EJ, Lee JH, Yang WM, Nam D, Lee JH, Lee SG, Um JY, Shim BS, Ahn KS. Simvastatin in combination with bergamottin potentiates TNF-induced apoptosis through modulation of NF-kappaB signalling pathway in human chronic myelogenous leukaemia. Pharm Biol. 2016 Oct;54(10):2050-60. PMID: 26911804", "BibTeX": "@article{26911804, title={Simvastatin in combination with bergamottin potentiates TNF-induced apoptosis through modulation of NF-kappaB signalling pathway in human chronic myelogenous leukaemia.}, author={Kim SM and Lee EJ and Lee JH and Yang WM and Nam D and Lee JH and Lee SG and Um JY and Shim BS and Ahn KS}, journal={Pharm Biol}, volume={54}, number={10}, pages={2050-60}}"}}]}